日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inhibition of SUMOylation Induces Adaptive Antitumor Immunity against Pancreatic Cancer through Multiple Effects on the Tumor Microenvironment.

SUMO化抑制通过对肿瘤微环境的多种影响诱导针对胰腺癌的适应性抗肿瘤免疫

Erdem Suna, Lee Hyojae James, Shankara Narayanan Jayanth Surya Narayanan, Tharuka Mohottige Don Neranjan, De la Torre Jorge, Ren Tianchen, Kuang Yixuan, Abeywardana Tharindumala, Li Kevin, Berger Allison J, Lowy Andrew M, White Rebekah R, Chen Yuan

"Empathy without sympathy": An analysis of support-related preferences among young adult cancer survivors

“同理心而非同情心”:对年轻癌症幸存者支持相关偏好的分析

Darabos, Katie; Berger, Allison J; Ford, Jennifer S

Cancer-Related Decision-Making Among Adolescents, Young Adults, Caregivers, and Oncology Providers

青少年、青年、照护者和肿瘤科医生在癌症相关决策中的参与情况

Darabos, Katie; Berger, Allison J; Barakat, Lamia P; Schwartz, Lisa A

The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.

NAE 抑制剂 pevonedistat 与 HDAC 抑制剂 belinostat 相互作用,通过破坏 DDR 来靶向 AML 细胞

Zhou Liang, Chen Shuang, Zhang Yu, Kmieciak Maciej, Leng Yun, Li Lihong, Lin Hui, Rizzo Kathryn A, Dumur Catherine I, Ferreira-Gonzalez Andrea, Rahmani Mohamed, Povirk Lawrence, Chalasani Sri, Berger Allison J, Dai Yun, Grant Steven

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

一项针对复发/难治性多发性骨髓瘤或淋巴瘤患者的新型在研NEDD8激活酶抑制剂Pevonedistat(MLN4924)的I期研究

Shah, Jatin J; Jakubowiak, Andrzej J; O'Connor, Owen A; Orlowski, Robert Z; Harvey, R Donald; Smith, Mitchell R; Lebovic, Daniel; Diefenbach, Catherine; Kelly, Kevin; Hua, Zhaowei; Berger, Allison J; Mulligan, George; Faessel, Hélène M; Tirrell, Stephen; Dezube, Bruce J; Lonial, Sagar

Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies

伊沙佐米(一种在研蛋白酶体抑制剂)治疗晚期非血液系统恶性肿瘤的1期研究

Smith, David C; Kalebic, Thea; Infante, Jeffrey R; Siu, Lillian L; Sullivan, Daniel; Vlahovic, Gordana; Kauh, John S; Gao, Feng; Berger, Allison J; Tirrell, Stephen; Gupta, Neeraj; Di Bacco, Alessandra; Berg, Deborah; Liu, Guohui; Lin, Jianchang; Hui, Ai-Min; Thompson, John A

Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924

利用NEDDylation抑制剂MLN4924克服卵巢癌临床前模型中的铂类耐药性

Jazaeri, Amir A; Shibata, Etsuko; Park, Jonghoon; Bryant, Jennifer L; Conaway, Mark R; Modesitt, Susan C; Smith, Peter G; Milhollen, Michael A; Berger, Allison J; Dutta, Anindya

Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins

人乳头瘤病毒16型E6和E7蛋白诱导宫颈角质形成细胞永生化过程中,胰岛素样生长因子结合蛋白3的表达增加。

Berger, Allison J; Baege, Astrid; Guillemette, Tracy; Deeds, James; Meyer, Ron; Disbrow, Gary; Schlegel, Richard; Schlegel, Robert